Iprazochrome: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__")
 
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Oxetoron}}
{{CMG}}; {{AE}} {{PB}}
'''''For patient information, click [[Oxetoron (patient information)|here]]'''''.{{Drugbox
| verifiedrevid = 444424244
| IUPAC_name = 3-hydroxy-1-isopropylindoline-5,6-dione 5-semicarbazone
| image = Iprazochrome.png
<!--Clinical data-->
| tradename = 
| Drugs.com = {{drugs.com|international|iprazochrome}}
| pregnancy_AU =<! -- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US =<! -- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU =<! -- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA =<! -- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK =<! -- GSL, P, POM, CD, or Class A, B, C -->
| legal_US =<! -- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = 
| routes_of_administration = 
<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 
<!--Identifiers-->
| CAS_number = 7248-21-7
| ATC_prefix = N02
| ATC_suffix = CX03
| PubChem = 6381821
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 903A9K181P
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07297
<!--Chemical data-->
| chemical_formula = 
| C=12 | H=16 | N=4 | O=3
| molecular_weight = 264.28 g/mol
| smiles = CC(C)N1CC(C2=CC(=NNC(=O)N)C(=O)C=C21)O
| synonyms = <small>[(3-hydroxy-1-isopropyl-6-oxo-2,3-dihydroindol-5-ylidene)amino]urea</small>
}}
'''Iprazochrome''' is an [[antimigraine]] agent.
It is a [[serotonin antagonist]].<ref name="pmid2639158">{{cite journal |author=Hampf G |title=Effect of serotonin antagonists on patients with atypical facial pain |journal=J Craniomandib Disord |volume=3 |issue=4 |pages=211–2 |year=1989 |pmid=2639158 |doi= |url=}}</ref>
==References==
{{reflist2}}
{{Antimigraine preparations}}
[[Category:Antimigraine drugs]]
[[Category:Alcohols]]

Revision as of 18:24, 10 February 2014


Template:Oxetoron Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

For patient information, click here.

Iprazochrome
File:Iprazochrome.png
Clinical data
Synonyms[(3-hydroxy-1-isopropyl-6-oxo-2,3-dihydroindol-5-ylidene)amino]urea
AHFS/Drugs.comInternational Drug Names
Pregnancy
category
  • AU: <! -- A / B1 / B2 / B3 / C / D / X -->
  • US: <! -- A / B / C / D / X -->
ATC code
Legal status
Legal status
  • AU: <! -- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
  • CA: <! -- Schedule I, II, III, IV, V, VI, VII, VIII -->
  • UK: <! -- GSL, P, POM, CD, or Class A, B, C -->
  • US: <! -- OTC / Rx-only / Schedule I, II, III, IV, V -->
Identifiers
CAS Number
PubChem CID
UNII
KEGG
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC12H16N4O3
Molar mass264.28 g/mol
3D model (JSmol)
  (verify)

Iprazochrome is an antimigraine agent.

It is a serotonin antagonist.[1]

References

Template:Reflist2


Template:Antimigraine preparations

  1. ↑ Hampf G (1989). "Effect of serotonin antagonists on patients with atypical facial pain". J Craniomandib Disord. 3 (4): 211–2. PMID 2639158.
Retrieved from "https://www.wikidoc.org/index.php?title=Iprazochrome&oldid=941484"